Results

Total Results: 7,637 records

Showing results for "therapy".

  1. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
    January 01, 2019 - 1.00 6.00 2.65 0.01 15,621,461 309,149.69 PCLASS_ORPROC Indicates operating room (major diagnostic or therapeutic … DRUG ABUSE OR DEPENDENCE, LEFT AMA 513 0.01% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 538 0.01% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 919 0.02% 897: ALCOHOL … /DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 6,836 0.12% 901: WOUND DEBRIDEMENTS FOR … W MCC 1,866 0.03% 920: COMPLICATIONS OF TREATMENT W CC 1,384 0.02% 921: COMPLICATIONS OF TREATMENT
  2. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
    January 01, 2016 - DRUG ABUSE OR DEPENDENCE, LEFT AMA 771 0.01% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 783 0.01% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 814 0.01% 897: ALCOHOL … /DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 8,130 0.13% 901: WOUND DEBRIDEMENTS FOR … MCC 7,686 0.12% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 34,021 0.54% 919: COMPLICATIONS OF TREATMENT … W MCC 1,559 0.02% 920: COMPLICATIONS OF TREATMENT W CC 1,328 0.02% 921: COMPLICATIONS OF TREATMENT
  3. www.ahrq.gov/sites/default/files/2024-01/higginson-report.pdf
    January 01, 2024 - Borrowing medications from one resident’s supply to sustain treatment for another resident when the … receives a drug prescribed that is not clinically indicated (contraindicated, known allergy, duplicate therapy … Error Category Wrong drug 7.3 5.0 4.1 6/4,481 or .001 Known allergy 11.7 12.9 14.4 Duplicate therapy … Orders Rate of Errors per 1000 Doses Wrong drug 0.6 1.2 1.3 Known allergy 1.5 0.9 Duplicate therapy
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
    June 11, 2019 - Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or before and after … P reexposure prophylaxis (PrEP) involves use of antiretroviral therapy regularly (eg, daily) or before … vs C: Mean age: 26 vs 25 vs 25 y Race: NR 30 (plasma) Good NIH Abbreviations: ART, antiretroviral therapy … FDA labeling information and perinatal antiretroviral treatment guidelines permit use of tenofovir diso … Challenges in systematic reviews that assess treatment harms.
  5. www.ahrq.gov/sites/default/files/2024-02/kleinman-report.pdf
    January 01, 2024 - Hospitalization for a Mental Illness, (6) Initiation and Engagement of Alcohol and Other Drug Dependence Treatment … a clinical rationale to allow for medications to be titrated up or down when used concurrently in therapy … the frequency or severity of the side effects but generally would not require a major alteration in therapy … interaction may result in an exacerbation of the patient's condition and/or require an alteration in therapy … Therefore, one interpretation of these data is that in vivo therapeutic trials are a common attempt
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/YALMYpRCoRSu9nhPFGudEm
    November 01, 2022 - helpful, and repeat serologic testing may be indicated.4 In symptomatic pregnant persons, antiviral therapy … Sexually transmitted infections treatment guidelines, 2021: genital herpes. … Accessed December 19, 2022. https://www.cdc.gov/std/treatment-guidelines/ herpes.htm 4. … Sexually transmitted infections treatment guidelines, 2021. … Accessed December 19, 2022. https://www.cdc.gov/std/ treatment/SexualHistory.htm 16.
  7. effectivehealthcare.ahrq.gov/products/infantile-hemangioma/policymaker
  8. digital.ahrq.gov/sites/default/files/docs/publication/r01hs014947-porter-final-report-2007.pdf
    January 01, 2007 - Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical … Physician evaluation and treatment had not yet been initiated; 6. … Any medication reported by the parent as being given on an ongoing basis or acutely for treatment of … recognizes potential tradeoffs between strength of evidence and the risk-benefit ratio of tests or treatments … of pain, UTI, asthma and otitis media (including weight-based doses, frequency and duration of therapy
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-survivor-care-transition_research-protocol.pdf
    March 27, 2013 - Brief The Increasing Population of Cancer Survivors and the Challenge of Transitioning From Cancer Treatment … survivors, including delayed detection of recurrences, suboptimal identification of symptom causes and treatments … considerations • Study design and size • Comparator used in comparative studies • Concurrent or previous treatments … Search (#1 AND #9) 0 #13 Search (#1 AND #9) Schema: all 0 Search (("Survivors"[MAJR] AND "Neoplasms/therapy … for cancer (i.e., treatment with curative intent).
  10. www.ahrq.gov/sites/default/files/2024-04/maraganore-report.pdf
    January 01, 2024 - patient was eligible for enrollment in a comparative effectiveness pragmatic trial that assigned a treatment … survival free at 12 months of discontinuation of the assigned drug or the prescription of an adjunctive therapy … Some initial programming errors in treatment assignments were resolved. … as captured by the EMR (Failure = the assigned treatment failed, Success = the assigned treatment succeed … , Pending = the assigned treatment outcome is pending).
  11. effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2010/research
  12. www.ahrq.gov/sites/default/files/2024-07/earp-report.pdf
    January 01, 2024 - This includes the sharing of decision making, risks, cost effectiveness, treatment regimens, goals and … of health disciplines, including health policy and administration, pharmacy, nursing, occupational therapy
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Jwn6dWRHvK3C9oJCV6hLKc
    September 05, 2017 - for identifying preschool children at higher risk for vision problems and the effectiveness of some treatments … ) and parent (worry about treatment, upset by treatments, arguments about treatment), it did not report … No studies evaluated potential effectiveness of treatments for reducing long­ term amblyopia or for … performance, function­ ing, or quality of life, and no eligible studies evaluated atropine or vision therapy … The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data
  14. effectivehealthcare.ahrq.gov/products/procalcitonin/research-protocol
  15. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018171-arora-final-report-2013.pdf
    January 01, 2013 - Treatment of HCV and eradication of the virus prevents future complications. … Very few patients receive treatment outside of the urban academic setting. … This information is extremely important for following patients on HCV treatment. … The patients’ response to treatment at week 4 is necessary to determine duration of therapy. … Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-tools_research-protocol.pdf
    April 14, 2016 - Center Measurement and Evaluation Tools25 and the and the Functional Assessment of Chronic Illness Therapy
  17. psnet.ahrq.gov/web-mm/intubation-mishap
    April 26, 2023 - would like to thank Jens Jensen, Joseph Cravero, and Dartmouth’s Pediatric ICU nursing and respiratory therapy … Delayed transmission Laboratory test results relevant to therapeutic decision are "lost" for several
  18. digital.ahrq.gov/sites/default/files/docs/resource/final-b14-archives-sarkar2075.pdf
    January 01, 2013 - been diagnosed and treated (usually with surgery, and possibly with chemotherapy and/or radiation therapy
  19. www.ahrq.gov/sites/default/files/2024-04/etchegaray-report.pdf
    January 01, 2024 - o Debriefings need to be done by trained professionals, because they can turn into therapy sessions
  20. www.ahrq.gov/sites/default/files/2024-07/nuckols-report.pdf
    January 01, 2024 - Affordable Care Act; poor health literacy, which reduces patients’ abilities to benefit from effective therapy … ; and diseases, such as cancer, for which more effective treatments would be highly valued.